Kyverna Therapeutics Inc. (KYTX)

2.61

-0.23 (-8.10%)

At close: Mar 03, 2025, 3:59 PM

2.59

-0.77%

After-hours: Mar 03, 2025, 04:00 PM EST

Kyverna Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21
Net Income	-60.37M	-28.89M	-26.35M
Depreciation & Amortization	1.71M	1.05M	586K
Stock-Based Compensation	2.22M	929K	7.25M
Other Working Capital	-659K	-7.03M	-5.66M
Other Non-Cash Items	605K	1.41M	829K
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	3.42M	-10.33M	-4.49M
Operating Cash Flow	-52.41M	-36.11M	-22.16M
Capital Expenditures	-621K	-768K	-1.29M
Acquisitions	n/a	n/a	n/a
Purchase of Investments	-54.85M	-56.49M	n/a
Sales Maturities Of Investments	46.68M	43.17M	n/a
Other Investing Acitivies	n/a	-13.33M	n/a
Investing Cash Flow	-8.79M	-14.1M	-1.29M
Debt Repayment	-781K	-249K	-41K
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	59.9M	12.13M	72.56M
Financial Cash Flow	58.12M	11.88M	72.52M
Net Cash Flow	-3.08M	-38.33M	49.08M
Free Cash Flow	-53.03M	-36.88M	-23.44M